2020 American Transplant Congress
A Video Education Intervention to Improve Kidney Transplant Knowledge and Willingness to Complete Transplant Evaluation in Dialysis Patients
*Purpose: The Centers for Medicare and Medicaid Services has set a goal of 30% (currently 18.5%) of dialysis patients to be on a transplant (Tx)…2020 American Transplant Congress
Using Quality Metrics to Improve Access to Living Donor Kidney Transplantation
*Purpose: Living donor kidney transplants (LDKT) are an excellent option for patients with kidney disease. Delays in donor evaluations can impact donor satisfaction as well…2020 American Transplant Congress
Belatacept Monthly Therapy: Transplant Recipients’ Experience
*Purpose: While graft and patient outcomes with belatacept have been relatively well documented, the decision to use belatacept for kidney transplant recipients rests in part…2020 American Transplant Congress
Cross-Sectional Survey to Assess Barriers to Medication Adherence in an Urban Transplant Population
University of Illinois, Chicago, IL
*Purpose: Non-adherence is a strong predictor of post-transplant outcome. Barriers to medication adherence (MA) include the cost and complexity of a medication regimen, education level,…2020 American Transplant Congress
Assessment of Deceased Donor Kidney and Liver Surgical Recovery Error Rates
Gift of Life Donor Program, Philadelphia, PA
*Purpose: There is no nationally available data related to the incidence of surgical errors in deceased donor organ recoveries or its impact on organ discard…2020 American Transplant Congress
Mindfulness at Methodist – Stress Resiliency Strategies for Patients
*Purpose: Stress triggers changes in the brain that make people appear distracted and forgetful. Chronic stress damages DNA, causes excess inflammation in the body, impairs…2020 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation: A Prospective Analysis Across Two Years
*Purpose: Previous trials have not examined 2-year longitudinal differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx)…2020 American Transplant Congress
Impact of Immunosuppression on Quality of Life among HLA-Identical Living Kidney Recipients at UCLA – A Qualitative Study
*Purpose: Tolerant kidney transplant recipients (off immunosuppression) report higher self-rated quality of life and a lower symptom burden compared to standard living recipients when using…2020 American Transplant Congress
Effect of Kidney Transplantation on Sleep Quality in Patients Admitted in ICU: A Cross-Section Study in China
Transplantation Center, Third Xiangya Hospital, Changsha, China
*Purpose: Although evidences showed that sleep disorder is common in patient with end stage renal disease (ESRD), less is known about their sleep quality after…2020 American Transplant Congress
Frailty is Strongly Associated with Self-Reported Symptom Burden among Patients with Cirrhosis Undergoing Evaluation for Liver Transplantation
University of California, San Francisco, San Francisco, CA
*Purpose: Among patients with cirrhosis, frailty has most commonly been measured using instruments that focus on malnutrition, muscle wasting, and functional impairment. Little is known…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 21
- Next Page »